Nanoscale Contrast Agents for Ultrasound Imaging of Musculoskeletal System

Overview

Journal Diagnostics (Basel)

Specialty Radiology

Date 2022 Nov 11

PMID 36359426

Authors

Xiaoyi Tang

Mengxin Zhao

Wei Li

Jiaqi Zhao

Affiliations

Soon will be listed here.

Abstract

Musculoskeletal ultrasound (MSKUS) has been recognized as an important method for the evaluation of diseases of the musculoskeletal system, and contrast-enhanced ultrasound (CEUS) technology is becoming an important branch of it. The development of novel materials and tiny nano-formulations has further expanded ultrasound contrast agents (UCAs) into the field of nanotechnology. Over the years, nanoscale contrast agents have been found to play an unexpected role in the integration of precise imaging for diagnosis and treatment of numerous diseases. It has been demonstrated that nanoscale UCAs (nUCAs) have advantages in imaging over conventional contrast agents, including superior biocompatibility, serum stability, and longer lifetime. The potential value of nUCAs in the musculoskeletal system is that they provide more reliable and clinically valuable guidance for the diagnosis, treatment, and follow-up of related diseases. The frontier of advances in nUCAs, their applications, and insights in MSKUS are reviewed in this paper.

Citing Articles

Nanomedicine and clinical diagnostics part I: applications in conventional imaging (MRI, X-ray/CT, and ultrasound).

Butt A, Bach H Nanomedicine (Lond). 2024; 20(2):167-182.

PMID: 39661327 PMC: 11731363. DOI: 10.1080/17435889.2024.2439776.

Ultrasonic-responsive piezoelectric stimulation enhances sonodynamic therapy for HER2-positive breast cancer.

Chen Z, Yang L, Yang Z, Wang Z, He W, Zhang W J Nanobiotechnology. 2024; 22(1):369.

PMID: 38918812 PMC: 11197237. DOI: 10.1186/s12951-024-02639-6.

Comparison of Ultrasound Contrast between HO-Responsive Nanoparticles and Microbubble Contrast According to Muscle Injury in Rat Models.

Kim D, Song N, Lee D, Kim G Diagnostics (Basel). 2023; 13(21).

PMID: 37958215 PMC: 10649825. DOI: 10.3390/diagnostics13213320.

Imaging in inflammatory arthritis: progress towards precision medicine.

Minopoulou I, Kleyer A, Yalcin-Mutlu M, Fagni F, Kemenes S, Schmidkonz C Nat Rev Rheumatol. 2023; 19(10):650-665.

PMID: 37684361 DOI: 10.1038/s41584-023-01016-1.

"Sweet" Hydrothorax in a Peritoneal Dialysis Patient. A Case Report and Review of the Literature on Novel Diagnostic and Therapeutical Approaches.

Bucur R, Botosineanu C, Donderski R Maedica (Bucur). 2023; 18(2):352-356.

PMID: 37588815 PMC: 10427105. DOI: 10.26574/maedica.2023.18.2.352.

References

Helbert A, von Wronski M, Colevret D, Botteron C, Padilla F, Bettinger T . Ultrasound Molecular Imaging With BR55, a Predictive Tool of Antiangiogenic Treatment Efficacy in a Chemo-Induced Mammary Tumor Model. Invest Radiol. 2020; 55(10):657-665. DOI: 10.1097/RLI.0000000000000661. View

Wu H, He Y, Wu H, Zhou M, Xu Z, Xiong R . Near-infrared fluorescence imaging-guided focused ultrasound-mediated therapy against Rheumatoid Arthritis by MTX-ICG-loaded iRGD-modified echogenic liposomes. Theranostics. 2020; 10(22):10092-10105. PMC: 7481417. DOI: 10.7150/thno.44865. View

Buch M, Eyre S, McGonagle D . Persistent inflammatory and non-inflammatory mechanisms in refractory rheumatoid arthritis. Nat Rev Rheumatol. 2020; 17(1):17-33. DOI: 10.1038/s41584-020-00541-7. View

Kim G, Song N, Park M, Kim T, Kim D, Oh Y . Diagnosis and Simultaneous Treatment of Musculoskeletal Injury Using HO-Triggered Echogenic Antioxidant Polymer Nanoparticles in a Rat Model of Contusion Injury. Nanomaterials (Basel). 2021; 11(10). PMC: 8537538. DOI: 10.3390/nano11102571. View

Gong Y, Li S, Zeng W, Yu J, Chen Y, Yu B . Controlled Bone Formation and Vascularization Using Ultrasound-Triggered Release of Recombinant Vascular Endothelial Growth Factor From Poly(D,L-lactic-co-glycolicacid) Microbubbles. Front Pharmacol. 2019; 10:413. PMC: 6491501. DOI: 10.3389/fphar.2019.00413. View

Kauscher U, Holme M, Bjornmalm M, Stevens M . Physical stimuli-responsive vesicles in drug delivery: Beyond liposomes and polymersomes. Adv Drug Deliv Rev. 2019; 138:259-275. PMC: 7180078. DOI: 10.1016/j.addr.2018.10.012. View

de Leon A, Perera R, Hernandez C, Cooley M, Jung O, Jeganathan S . Contrast enhanced ultrasound imaging by nature-inspired ultrastable echogenic nanobubbles. Nanoscale. 2019; 11(33):15647-15658. PMC: 6716144. DOI: 10.1039/c9nr04828f. View

Ntoulia A, Barnewolt C, Doria A, Ho-Fung V, Lorenz N, Mentzel H . Contrast-enhanced ultrasound for musculoskeletal indications in children. Pediatr Radiol. 2021; 51(12):2303-2323. DOI: 10.1007/s00247-021-04964-6. View

Alheshibri M, Craig V . Armoured nanobubbles; ultrasound contrast agents under pressure. J Colloid Interface Sci. 2018; 537:123-131. DOI: 10.1016/j.jcis.2018.10.108. View

10.

Xie M, Luo S, Li Y, Lu L, Deng C, Cheng Y . Intra-articular tracking of adipose-derived stem cells by chitosan-conjugated iron oxide nanoparticles in a rat osteoarthritis model. RSC Adv. 2022; 9(21):12010-12019. PMC: 9063530. DOI: 10.1039/c8ra09570a. View

11.

Sidhu P, Cantisani V, Dietrich C, Gilja O, Saftoiu A, Bartels E . The EFSUMB Guidelines and Recommendations for the Clinical Practice of Contrast-Enhanced Ultrasound (CEUS) in Non-Hepatic Applications: Update 2017 (Short Version). Ultraschall Med. 2018; 39(2):154-180. DOI: 10.1055/s-0044-101254. View

12.

Alphandery E . Ultrasound and nanomaterial: an efficient pair to fight cancer. J Nanobiotechnology. 2022; 20(1):139. PMC: 8930287. DOI: 10.1186/s12951-022-01243-w. View

13.

Thakur S, Chen Y, Houston Z, Fletcher N, Barnett N, Thurecht K . Ultrasound-responsive nanobubbles for enhanced intravitreal drug migration: An ex vivo evaluation. Eur J Pharm Biopharm. 2019; 136:102-107. DOI: 10.1016/j.ejpb.2019.01.014. View

14.

Kunz P, Kiesl S, Gross S, Kauczor H, Schmidmaier G, Fischer C . Intra-observer and Device-Dependent Inter-observer Reliability of Contrast-Enhanced Ultrasound for Muscle Perfusion Quantification. Ultrasound Med Biol. 2019; 46(2):275-285. DOI: 10.1016/j.ultrasmedbio.2019.10.007. View

15.

Danielsen M, Hempel C, Andresen T, Urquhart A . Biopharmaceutical nanoclusters: Towards the self-delivery of protein and peptide therapeutics. J Control Release. 2022; 347:282-307. DOI: 10.1016/j.jconrel.2022.04.050. View

16.

Selmani A, Kovacevic D, Bohinc K . Nanoparticles: From synthesis to applications and beyond. Adv Colloid Interface Sci. 2022; 303:102640. DOI: 10.1016/j.cis.2022.102640. View

17.

Cheng B, Ahn H, Nam H, Jiang Z, Gao F, Minn I . A Unique Core-Shell Structured, Glycol Chitosan-Based Nanoparticle Achieves Cancer-Selective Gene Delivery with Reduced Off-Target Effects. Pharmaceutics. 2022; 14(2). PMC: 8878887. DOI: 10.3390/pharmaceutics14020373. View

18.

Chen L, Ji Y, Hu X, Cui C, Liu H, Tang Y . Cationic poly-l-lysine-encapsulated melanin nanoparticles as efficient photoacoustic agents targeting to glycosaminoglycans for the early diagnosis of articular cartilage degeneration in osteoarthritis. Nanoscale. 2018; 10(28):13471-13484. DOI: 10.1039/c8nr03791d. View

19.

Exner A, Kolios M . Bursting Microbubbles: How Nanobubble Contrast Agents Can Enable the Future of Medical Ultrasound Molecular Imaging and Image-Guided Therapy. Curr Opin Colloid Interface Sci. 2021; 54. PMC: 8356903. DOI: 10.1016/j.cocis.2021.101463. View

20.

Negishi Y, Ishii Y, Shiono H, Akiyama S, Sekine S, Kojima T . Bubble liposomes and ultrasound exposure improve localized morpholino oligomer delivery into the skeletal muscles of dystrophic mdx mice. Mol Pharm. 2014; 11(3):1053-61. DOI: 10.1021/mp4004755. View